SCHEMBL30229840

SCHEMBL30229840

OC(c1ncc[nH]1)c1nccs1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
F2RL1 P55085 19/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5548986 0.79 ADRA2A (0.42) F2RL1
SCHEMBL6957930 0.78 F2RL1 (0.39) F2RL1
SCHEMBL9501488 0.78 F2RL1 (0.46) F2RL1
SCHEMBL4768669 0.78 ALDH1A1 (0.42)
SCHEMBL6953469 0.75 F2RL1 (0.36) F2RL1
SCHEMBL2887479 0.69
SCHEMBL30230708 0.69 F2RL1 (0.42) F2RL1
SCHEMBL6848050 0.67 ALOX5 (0.52)
SCHEMBL2205006 0.67 F2RL1 (0.48) F2RL1
SCHEMBL23863035 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4376840-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS Nura Bio, Inc. (US) 2024-06-05 EP claimed
WO-2023009663-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS NURA BIO, INC. (US) 2023-02-02 WO claimed